BACKGROUND: Data suggest that the prediction of adult cardiovascular disease using a model comprised entirely of adult nonlaboratory-based risk factors is equivalent to an approach that additionally incorporates adult lipid measures. We assessed and compared the utility of a risk model based solely on nonlaboratory risk factors in adolescence versus a lipid model based on nonlaboratory risk factors plus lipids for predicting high-risk carotid intima-media thickness (cIMT) in adulthood.
A
therosclerosis is a multifactorial disease with its roots in childhood, 1 suggesting that primary prevention of cardiovascular diseases would ideally be targeted to children and adolescents. Recent pediatric guidelines in cardiovascular disease (CVD) risk assessment recommend universal (population-wide) lipid screening in youth. 2 However, efforts to create a risk stratification system that could be implemented cost-effectively and on a large scale, based on routine and easily collected measures and without a need for additional laboratory testing, are needed. A study in adults 3 showed promising results supporting this kind of approach, with a nonlaboratory-based risk model predicting cardiovascular events as accurately as one that relied on laboratory-based measurements.
Increased carotid intima-media thickness (cIMT), as assessed noninvasively by ultrasound, is a marker of structural atherosclerosis. 4 We and others have previously shown that elevated risk factors in youth predict greater cIMT in adulthood. 1 cIMT has also been shown to be an independent risk factor for cardiovascular events. 5 Thus, in the absence of cardiovascular events, measurements of cIMT by noninvasive imaging techniques provide a surrogate end point to assess early atherosclerosis. 4 In this study, we use data from 4 cohort studies of cardiovascular risk factors initiated in childhood that have followed participants into adulthood: the Cardiovascular Risk in YFS (Young Finns Study, Finland), 1 the CDAH Study (Childhood Determinants of Adult Health, Australia), 6 the BHS (Bogalusa Heart Study, United States), 7 and the IS (Insulin Study, United States). 8, 9 Our aim was to compare risk prediction models based on nonlaboratory versus nonlaboratory plus lipids data obtained during adolescence for predicting high-risk cIMT in adulthood. For simplicity, in the text we refer to the nonlaboratory plus lipids model as a lipid model.
METHODS

Study Sample
Data were analyzed in 2893 participants 12 to 18 years of age at baseline from 4 longitudinal cohort studies with mean follow-up of 23.4 years. Each study was approved by the appropriate institutional review boards, and written informed consent or assent was obtained from all the study participants >18 years of age, or assent from the participants and consent from their parents for participants <18 years of age. Risk factors in each cohort were measured as part of selective screening. None of the participants was using lipid-lowering or antihypertensive medication or diagnosed with type 2 diabetes mellitus at baseline. Participants with type 1 diabetes mellitus were excluded from the present study. The data, analytic methods, and study materials will not be made available to other researchers outside the International Childhood Cardiovascular Cohort consortium for purposes of reproducing the results or replicating the procedure. Researchers interested in the data, methods, or analysis can contact the corresponding author for more information.
Cardiovascular Risk in Young Finns Study
The YFS sample has been previously described in detail. 1 YFS is an ongoing epidemiological cohort study. In 1980, 3596 children and adolescents 3, 6, 9, 12, 15, and 18 years of age participated in the first cross-sectional examination. Study participants were chosen randomly from national population registers from 5 Finnish university cities and their rural surroundings. The majority of subjects in the present study were from YFS, including 2079 participants 12, 15, and 18 years of age at baseline (1986) and who had low-density lipoprotein (LDL) cholesterol and high-density lipoprotein (HDL) cholesterol and smoking data at baseline and carotid artery ultrasonography data in 2001 (27, 30 , and 33 years of age) or 2007 (33, 36 , and 39 years of age). Data from the most recent visit that included measurement of cIMT were used to maximize the follow-up period.
Childhood Determinants of Adult Health
The CDAH sample has been described in detail elsewhere. 6 CDAH baseline data were collected in 1985 on a representative sample of 8498 school children 7 to 15 years of age as
Clinical Perspective
What Is New?
• Nonlaboratory-based risk factors (sex, blood pressure status, body mass index status) and lipids (high-density lipoprotein cholesterol and lowdensity lipoprotein cholesterol status) measured in adolescence independently predicted high-carotid intima-media thickness, a marker of preclinical atherosclerotic cardiovascular disease, in young adulthood.
• The addition of lipid measurements to a prediction model that only considered nonlaboratory-based risk factors provided a clinically modest improvement in the ability to predict adolescents likely to develop high-carotid intima-media thickness in adulthood.
What Are the Clinical Implications?
• In the absence of information on lipids, risk assessment using only nonlaboratory-based risk factors might be a useful alternative in predicting adolescents at risk of developing adult preclinical atherosclerotic cardiovascular disease.
• Future research should determine the utility of multiple lipid and nonlaboratory-based risk factor measurements collected throughout youth to the prediction of adult preclinical atherosclerotic cardiovascular disease. 
Bogalusa Heart Study
The BHS sample has also been described in detail elsewhere. 7 The BHS is a biracial community-based investigation of the early natural history of CVD. For this analysis, 436 participants 12 to 18 years of age at baseline who had risk factor data available from either the 1984 to 1985 or 1987 to 1988 crosssectional surveys (baseline) and had measures including ultrasound data collected during 2001 to 2010 (follow-up) were included. Data from the first and most recent visits were used to maximize the follow-up period.
Insulin Study
The IS has been described in detail elsewhere. 8, 9 The initial cohort was selected randomly after blood pressure (BP) screening of 12 043 fifth-to eighth-grade public school children. This analysis included data on 106 participants who were measured between 2000 and 2008 at 17 to 18 years of age and who had adulthood risk factor measurements available at 21 to 24 years of age.
Clinic Measurements and Smoking Status
Height and weight were measured at all time points. Body mass index (BMI) was calculated using the formula weight (kg)/height (m). 2 A random zero sphygmomanometer was used to measure BP in the YFS, BHS, and IS. In CDAH, BP was measured with a standard mercury sphygmomanometer at childhood and a digital automatic monitor (Omron HEM907, Omron Healthcare Inc) at adulthood. In YFS, the average of 3 measurements of the first and fifth Korotkoff sounds was used to define systolic and diastolic BP. The mean of 2 measurements was used in the CDAH, BHS, and IS analyses. Venous blood samples were taken after a 12-hour fast from the antecubital vein. In YFS at baseline, serum cholesterol and triglycerides were measured using fully enzymatic Boehringer CHOD-PAP kits with an OLLI 3000 analyzer. Subsequently, an Olympus System reagent analyzer in a clinical chemistry analyzer (AU400, Olympus) was used to determine lipid levels. Serum HDL cholesterol was measured by the dextran sulfate 500 000 method. In CDAH in 1985, serum total cholesterol and triglycerides were determined according to the Lipid Research Clinics Program, and HDL cholesterol was analyzed after precipitation of apolipoprotein B-containing lipoproteins with heparin-manganese. 10 In BHS, the HDL cholesterol and triglycerides were measured using chemical procedures with a Technicon Auto Analyzer II (Technicon Instrument Corp), according to the laboratory manual of the Lipid Research Clinics Program. 11 LDL cholesterol was calculated using the Friedewald formula. 12 Since baseline years, these variables were determined by enzymatic procedures using the Abbott VP instrument (Abbott Laboratories). 13 Serum concentrations of LDL and HDL cholesterol were analyzed by a combination of heparin-calcium precipitation and agar-agarose gel electrophoresis procedures. In IS, serum lipids were analyzed in the University of Minnesota laboratory with a Cobas FARA.
14 HDL cholesterol was determined after precipitation of non-HDL lipoproteins with a dextran-sulfate magnesium precipitating reagent. Triglycerides were determined with a standard glycerol blanked enzymatic triglyceride method. LDL cholesterol was calculated using the Friedewald formula in YFS, CDAH, and IS. 12 The coefficient of variation for within-assay precision in YFS was 2.2% for total cholesterol, 2.3% for HDL cholesterol, and 3.8% for serum triglycerides. Both US cohorts and CDAH used chemical and enzymatic procedures meeting the performance requirements of the Lipid Clinics Program and Lipid Standardization Program of the Centers for Disease Control and Prevention, which routinely monitors the accuracy of measurements of total cholesterol, triglyceride, and HDL cholesterol concentrations. Participants were asked a series of questions about smoking at baseline. Details of these questionnaires are presented in the online-only Data Supplement. Responses were collapsed into a binomial categorical variable indicating (1) regular smoking or ≥5 cigarettes per week, and (2) no smoking or <5 cigarettes per week. Physical activity was assessed by using a self-administered questionnaire at baseline in the YFS cohort only (see the online-only Data Supplement).
Carotid Artery Ultrasound Studies
B-mode ultrasound studies of the left carotid artery were performed at follow-up examinations using standardized protocols for each study described in detail elsewhere. 1, [15] [16] [17] In YFS, to assess intraindividual reproducibility of ultrasound measurements, 57 participants were reexamined 3 months after the initial visit. The average absolute difference and SD between measurements was 0.05±0.04 mm. In CDAH, reproducibility for replicate maximum cIMT measurements was assessed in a random sample of 30 participants. The average absolute difference and SD was 0.02±0.04 mm. In BHS, 75 participants underwent repeat ultrasound examinations 10 to 12 days after their initial visit to determine intraindividual reproducibility. The average absolute difference and SD between measurements for all cIMT segments was 0.05±0.03 mm. In IS, reproducibility of the cIMT showed a mean difference±SD of 0.02±0.03 for analyses separated by 1 week.
Definition of High cIMT in Adulthood
cIMT in adulthood was defined as ≥90th percentile for study cohort-and study year-specific values. In sensitivity analyses, similar results were found using cut points corresponding to the 80th cIMT percentiles (data not shown).
Definition of Risk Factors During Adolescence
Because of generalizability of these data to the clinical setting and to be consistent with current recommendations, we analyzed the data by using categorical adolescent risk factors classified according to the recent recommendations from the Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents. 2 This enabled standardization among cohorts by adjusting to the same external standard while accounting for age-, sex-, and height-(where appropriate) specific growth patterns. Overweight status was defined according to the Cole classification of BMI. 18 Prehypertension or hypertension was defined according to the Fourth Report on High Blood Pressure in Children and Adolescents from the National High Blood Pressure Education Program. 19 High-risk plasma lipid levels were defined according to the National Cholesterol Education Program Expert Panel on Cholesterol Levels in Children. 20 However, because of differences in the range of risk factor levels among the cohorts and changes in secular trends, 21 the main analyses were also performed by using study-and visitspecific Z scores. The results were similar in terms of the direction of effect and level of significance with results obtained from the main analyses. Detailed results and discussion from these analyses are presented in the text and in the online-only Data Supplement.
Statistical Methods
Statistical analyses were performed with SAS 9.4. Statistical significance was inferred at a 2-tailed value of P≤0.05. The normality assumptions of the residuals were assessed by examining histograms of the residuals and normal probability plots. The residuals were normally distributed. Values for plasma triglycerides were log e -transformed to correct for skewness. No significant interactions were observed between sex and adolescent risk factors with continuous ultrasound variables, indicating that the associations of risk markers and ultrasound variables were similar between sexes. Therefore, data from males and females were combined in all models. In the online sensitivity analyses, study cohort-and study yearspecific Z scores were constructed for each adolescent risk factor. Age-and sex-adjusted ANOVA was used to compare differences in characteristics among study groups. Risk ratios and 95% confidence intervals (CIs) were estimated using log binomial regression and used to examine associations between adolescent risk measurements and adulthood risk for high cIMT. Linear and polynomial regression models were used to examine the associations for the nonlaboratory and lipid measurements with adult preclinical atherosclerosis. The ability of nonlaboratory and lipid risk data in adolescence to predict high cIMT in adulthood was assessed using area under receiver-operating characteristic curves (AUC), category-free net reclassification improvement (NRI), and integrated discrimination improvement (IDI) measures. Calibration was assessed by using the Hosmer-Lemeshow χ 2 goodness-of-fit test. Additionally, for each event using Poisson regression, we estimated the event probability under the nonlaboratory model (age, sex, BMI, BP, smoking) and under the lipid model (nonlaboratory plus lipids). Improvement in prediction probability (IPP) was estimated as the observed risk difference as a function of the reclassification probability, that is, the alternative probability minus base probability, in which each probability was the individual solution to the whole regression equation (expected value of the mean for each individual). The logic of IPP is as follows. For fixed expected risk for an individual under the base model IPP, if the expected risk under the alternative model is less, then the observed risk should be less; and if the expected risk under the alternative model is more, then the observed risk should be greater. IPP was operationalized in 2 ways: (1) the differential observed event rate for those whose reclassification probability was negative (classified to lower risk status) compared with those whose reclassification probability was positive (classified to higher risk status), and (2) the P value of the regression coefficient of observed higher cIMT on the reclassification probability. In both methods, we also adjusted for base risk. Details of this method are described elsewhere.
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RESULTS
Baseline Characteristics
Baseline risk factors stratified by study cohort, with age-and sex-adjusted differences, are shown in Table 1 . The gender distribution was similar among study groups, but significant differences were observed for BP, BMI, lipids, and smoking among the cohorts (all P<0.0002). 
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Nonlaboratory-Versus Lipid-(ie, Nonlaboratory With Lipid Measurements) Based Risk Assessment in Predicting High cIMT in Adulthood
Univariate analyses (Table 2 ) assessing relations between risk factors and cIMT showed significant associations for age, sex, and categorical risk factors (BMI, smoking, LDL cholesterol, and HDL cholesterol). Table 3 shows the results for a multivariable model assessing risk ratios for high cIMT (≥90th percentile) in adulthood according to nonlaboratory and lipid risk factors measured during adolescence. Among the nonlaboratory risk factors, sex, categorical BMI, and categorical BP were significantly associated with high cIMT. When lipids were introduced into the model, the significant association remained for sex, overweight, obesity, prehypertension/hypertension, borderline high LDL cholesterol, high LDL cholesterol, and borderline low HDL. Similar associations were observed for study-and visitspecific continuous Z score risk factors (Tables I and II in the online-only Data Supplement). Figure 1 shows the receiver operating characteristic curves for nonlaboratory model (BP,
When study cohorts were analyzed separately, no significant differences between models were observed: for YFS, the nonlaboratory-based AUC was 0. Table 4 provides data to compare the utility of nonlaboratory-versus lipid-based risk assessment in predicting adult high cIMT. Adding lipids to the nonlaboratory model significantly improved the AUC, IDI, and NRI values as shown in model 1 (P always <0.04). Model 2 shows the results when a comparison was made between nonlaboratory and modified lipid models where BMI is removed from the lipid model. AUCs were now similar between the models (in model 2) predicting high cIMT (P for difference, 0.39). In addition, neither IDI nor NRI (0.007 and 0.002, P for difference, always >0.10) changed significantly with the lipid-based model compared with the nonlaboratory-based model (Table 4) . Goodness of fit indicated by the Hosmer-Lemeshow χ 2 was acceptable for all models examined. The IPP reclassification of high cIMT probability based on adding lipids to the base regression equation led to an improvement in prediction (Table 5 ). Cumulative incidence for high cIMT was 6.35% in participants whose risk was reclassified downward by adding lipids versus 9.70% in participants whose risk was reclassified upward with an absolute difference of 3.35% (P=0.0021), which means an added discrimination of 43% of the average risk for everyone. The cumulative risk does not account for time between risk factor and cIMT measurements. The Poisson model, which does account for elapsed time, showed similar results but lower reclassification ORIGINAL RESEARCH ARTICLE percentages compared with the linear model (5.59% in participants whose risk was reclassified downward versus 8.09% in participants whose risk was reclassified upward; P for difference, 0.0078). Figure 2 shows the incremental value of cumulative risk factor burden. Nonlaboratory risks included overweight or obese, elevated BP, and smoking. Lipid risk factors additionally included elevated LDL and triglyceride levels and low HDL levels. Risk for developing high cIMT in adulthood was similar whether a participant had a positive risk for all 3 nonlaboratory risk factors (relative risk [RR], 10.6; 95% CI, 4.0-28.4) or had positive risk for all 6 risk factors, including lipid measurements (RR, 6.9; 95% CI, 1.2-41.4; P for difference, 0.59).
Sensitivity analyses were conducted using study-and visit-specific Z scores. The C statistics (95% CI) were 0.698 (0.667-0.731) for the nonlaboratory measurements and 0.717 (0.685-0.748) for the lipid measurements ( Figure I in the online-only Data Supplement). This difference was statistically significant (P=0.022). IDI and NRI values (0.010 and 0.32, respectively; P always <0.0002) showed small but significantly better discrimination for lipid-based risk factors compared with nonlaboratory risk factors (Table III in the onlineonly Data Supplement). The IPP reclassification of high cIMT probability based on adding LDL, triglycerides, Data are pooled (N = 2893 for both nonlaboratory and laboratory models). High cIMT, study cohort-specific ≥90th percentile. The International System of Units conversion to mg/dL for lipids: LDL, normal <110 mg/dL, borderline high 110-129 mg/dL, high ≥130 mg/dL; triglycerides, normal <90, borderline high 90-129 mg/dL, high ≥130 mg/dL; HDL, normal >45 mg/dL, borderline low 40-45 mg/dL, low <40 mg/dL. BMI indicates body mass index; CI, confidence interval; cIMT, carotid intima media thickness; HDL, highdensity lipoprotein; LDL, low-density lipoprotein; Ref, reference; and RR, relative risk.
*Age-and sex-specific values defined according to the Fourth Report on High Blood Pressure in Children and Adolescents from the National High Blood Pressure Education Program. 19 †Age-and sex-specific values defined according to the Cole classification. 18 
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and HDL to the nonlaboratory regression equation led to an improvement in prediction (Table IV in the onlineonly Data Supplement). Cumulative incidence for high cIMT was 7.2% in subjects whose risk was reclassified downward by adding lipids versus 11.2% in subjects whose risk was reclassified upward with a difference of 4.0% (P=0.0005). Further analysis was done by using study-specific risk factor Z scores to calculate whether replacing LDL cholesterol with non-HDL cholesterol would improve the prediction model When triglycerides and HDL cholesterol were replaced with the triglyceride/HDL cholesterol ratio in the lipid model, the prediction values for AUC and NRI for high adult cIMT were no longer statistically significant compared with the nonlaboratory model: AUC (95% CI), 0.709 (0.677-0.741), P value 0.11; IDI, 0.0046, P value, 0.01; NRI, 0.067, P value, 0.067. Additional analyses were made using insulin as a marker of insulin resistance in childhood. Insulin data were available for 2475 participants from the YFS, BHS, and IS cohorts. Prediction was not improved when insulin was included in the lipids model (model 1) compared with lipids model without insulin (AUC, NRI, and IDI P values always >0.11). Results for the YFS, BHS, and IS cohorts are presented in Table III in the online-only Data Supplement. Although physical activity data were not available in all cohorts, a physical activity index was obtained at baseline in the YFS cohort (see the onlineonly Data Supplement). The results remained similar (data not shown) when this was added to separate analyses conducted in the YFS.
DISCUSSION
The findings from 4 international cohorts examined in this study show that the risk of early atherosclerosis, represented by measurements of cIMT in young adults, could be predicted by nonlaboratory measures (BMI, BP, smoking) of CVD risk factors in adolescence. The addition of blood lipids statistically improved models of prediction for preclinical atherosclerosis in adulthood.
In prior reports from these and other cohorts, it has been shown that childhood risk factors, and especially their clustering, are predictive of adult cIMT, as well as other noninvasive measures of preclinical atherosclerosis. 1, 17 Moreover, findings from the BHS and PDAY study (Pathobiological Determinants of Atherosclerosis in Youth) have shown that CVD risk factors are strongly associated with early atherosclerotic lesions found in autopsies of youth dying from non-CVD related causes. 7 The findings in this study are consistent with these earlier observations showing the relation of early risk factor profiling to CVD pathophysiology.
In the NHANES (National Health and Nutrition Examination Survey) I adult population (baseline, 25-74 years of age, N=14 407), Gaziano et al 3 examined whether a risk prediction method that did not require any laboratory tests could be as accurate as one requiring laboratory information. They observed that a model with nonlaboratory-based risk factors predicted cardiovascular events as accurately as one that relied on laboratorybased values. The nonlaboratory model included age, BP, smoking, BMI, history of diabetes mellitus, and history of BP treatment, whereas in the laboratory-based model, BMI was replaced with total cholesterol levels. Consistent with these previous data, our findings from 4 cohort studies among youth 12 to 18 years of age (with no history of diabetes mellitus or treatment for BP and hypercholesterolemia) were essentially similar concerning the association between adolescent risk factors and increased cIMT when the laboratory-based model substituted BMI for lipids-a similar approach to that used by Gaziano et al. 3 In the present study, the results also showed statistically better discrimination for laboratorybased risk factors over nonlaboratory-based risk factors when BMI was included in both models. Although the addition of blood lipids statistically improved models of prediction for future preclinical atherosclerosis, the difference was modest with unclear clinical significance. Further studies are needed to clarify the predictive utility from measuring lipids at this age.
We have previously found in a pediatric setting by using pooled data from the YFS and BHS cohorts that high BMI alone was as good as and in some cases was superior to clustering of risk factors (high insulin, low HDL cholesterol, high triglycerides, high BP, and high BMI) in predicting high cIMT in adulthood. 23 Moreover, our previous analyses have shown an increase in CVD risk associated with childhood overweight or obesity and the tracking of adiposity between childhood and adulthood. 24 It was also stipulated that 1 measurement of BMI is more accurate than 1 measurement of the laboratory components. It is not known whether prediction using a lipid model could be improved by including lipid measurements obtained at repeated clinic visits over time. 25 Repeated lipid measurements were not available in the present study. These findings about the impact of lipids on future cIMT should be interpreted with caution given the biological variability in lipid measurements.
Based on the present study, the cumulative risk factor burden was quite similar between the nonlaboratory and lipid models, suggesting that a risk assessment using only nonlaboratory data are a useful alternative in the absence of information on lipids in predicting adult preclinical atherosclerosis. This would allow the immediate identification of youth at elevated risk who might benefit from a therapeutic lifestyle intervention. Obvious benefits include avoiding the need to subject a child to a blood draw. Additional costs associated with lipid measurement in childhood could include unnecessary worry and time to interpret and follow up on results. The revised pediatric guidelines recommend lipid screening for identifying familiar hypercholesterolemia and predicting atherosclerosis. 2 We acknowledge that our findings do not address the question of screening for familiar hypercholesterolemia in childhood, which is an important reason to measure lipid levels in childhood.
Although strong evidence suggests that CVD has its origins in childhood, 1 there is no widely accepted childhood risk stratification system that uses risk factor data obtained from apparently healthy youths. From the PDAY data, a risk score has been developed estimating the probability for coronary artery lesions observed in autopsy, but it is only applicable for individuals 15 to 34 years of age. 26, 27 After performing risk stratification, the main issue is how to intervene among high-risk children. In this sense, the results from the STRIP study (Special Turku Coronary Risk Factor Intervention Project for Children) show promise, in that dietary intervention initiated in infancy has shown favorable effects on cardiovascular risk factors and arterial function. 28 In addition, among children with extreme cardiovascular risk, such as in familiar hypercholesterolemia, statins have been shown to be effective in reducing the progression of preclinical atherosclerosis, 29 although long-term efficacy has not been determined. Much variation exists in smoking across countries, regions, races, and social groups. During the past 3 decades, smoking prevalence among youth has fluctuated in unexpected ways that may have an impact on epidemiological studies. Although major [18] [19] [20] or participant-reported smoking, the risk factor was considered positive. BMI indicates body mass index; cIMT, carotidintima media thickness; HDL, high-density lipoprotein; and LDL, low-density lipoprotein.
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efforts have taken place to reduce smoking among adolescence, new trends such as other drug use have increased the use of tobacco among youths. 30 The main strength of this study is the use of pooled data on childhood risk factors and adult cIMT from 4 international longitudinal cohorts. However, the study has some potential limitations. First, because the study cohorts are comprised of young adults at follow-up, it was not possible to study associations between risk factors and definite cardiovascular events. Instead, we have used cIMT as a surrogate end point, but one that has been associated with future overt CVD. Second, study participants were predominantly white, and the results may not be generalizable to other ethnicities. Third, we were unable to consider pubertal stage or family history, both of which have an influence on CVD risk factors, because data were not available for all cohorts. Waist circumference could not be used because it was not collected at baseline in these cohorts. However, BMI, which is highly correlated to waist circumference, has previously been shown to give similar results to waist circumference in pediatric settings. 31, 32 Finally, the analyses were based on adolescent risk factors, so the analyses are not necessarily applicable in younger children. However, we have previously shown that the association between childhood risk factors and adult preclinical atherosclerosis is weak or nonsignificant before 11 years of age.
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CONCLUSIONS
In summary, our data from 4 international cohort studies show that nonlaboratory risk factors and lipids independently predict preclinical atherosclerosis in young adulthood. Although we found the predictive value of an approach that additionally considered lipids to be statistically superior to an approach that only considered nonlaboratory factors, the clinical utility of lipid measurements remains uncertain given the modest improvements in risk prediction of preclinical atherosclerosis.
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